Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman has maintained an Equal-Weight rating on Colgate-Palmolive (NYSE:CL) and increased the price target from $75 to $82.
January 16, 2024 | 5:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Equal-Weight rating on Colgate-Palmolive and raised the price target to $82, indicating a positive outlook on the stock.
The increase in price target by Barclays reflects a positive reassessment of Colgate-Palmolive's valuation, which could lead to increased investor confidence and a potential short-term rise in the stock price. The Equal-Weight rating suggests that Barclays views the stock as fairly valued at the current level, but the raised target indicates an expectation of some upside. This news is directly related to Colgate-Palmolive and is likely to be important to investors, as analyst ratings and price targets can influence market perception and investment decisions.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100